BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25704289)

  • 1. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.
    Wang LQ; Wong KY; Rosèn A; Chim CS
    Oncotarget; 2015 Dec; 6(42):44422-36. PubMed ID: 26517243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A negative feedback loop between miR-200b and the nuclear factor-κB pathway via IKBKB/IKK-β in breast cancer cells.
    Wu H; Wang G; Wang Z; An S; Ye P; Luo S
    FEBS J; 2016 Jun; 283(12):2259-71. PubMed ID: 26433127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway.
    Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS
    Mol Cancer; 2013 Dec; 12():173. PubMed ID: 24373626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
    Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
    Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
    Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
    DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
    Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
    Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
    Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
    Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-136-5p Regulates the Inflammatory Response by Targeting the IKKβ/NF-κB/A20 Pathway After Spinal Cord Injury.
    Deng G; Gao Y; Cen Z; He J; Cao B; Zeng G; Zong S
    Cell Physiol Biochem; 2018; 50(2):512-524. PubMed ID: 30308489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide screening reveals that miR-195 targets the TNF-α/NF-κB pathway by down-regulating IκB kinase alpha and TAB3 in hepatocellular carcinoma.
    Ding J; Huang S; Wang Y; Tian Q; Zha R; Shi H; Wang Q; Ge C; Chen T; Zhao Y; Liang L; Li J; He X
    Hepatology; 2013 Aug; 58(2):654-66. PubMed ID: 23487264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
    Wang LQ; Chim CS
    Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer.
    Zhang Y; Wang X; Xu B; Wang B; Wang Z; Liang Y; Zhou J; Hu J; Jiang B
    Oncol Rep; 2013 Oct; 30(4):1976-84. PubMed ID: 23900443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-199b promotes the acute spinal cord injury through IKKβ-NF-κB signaling pathway activating microglial cells.
    Zhou HJ; Wang LQ; Xu QS; Fan ZX; Zhu Y; Jiang H; Zheng XJ; Ma YH; Zhan RY
    Exp Cell Res; 2016 Nov; 349(1):60-67. PubMed ID: 27693495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MicroRNA-Mediated Positive Feedback Regulatory Loop of the NF-κB Pathway in Litopenaeus vannamei.
    Zuo H; Yuan J; Chen Y; Li S; Su Z; Wei E; Li C; Weng S; Xu X; He J
    J Immunol; 2016 May; 196(9):3842-53. PubMed ID: 26994223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA analysis suggests an additional level of feedback regulation in the NF-κB signaling cascade.
    Mechtler P; Singhal R; Kichina JV; Bard JE; Buck MJ; Kandel ES
    Oncotarget; 2015 Jul; 6(19):17097-106. PubMed ID: 26020802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small RNA and transcriptome sequencing reveal the role of miR-199a-3p in inflammatory processes in cystic fibrosis airways.
    Bardin P; Marchal-Duval E; Sonneville F; Blouquit-Laye S; Rousselet N; Le Rouzic P; Corvol H; Tabary O
    J Pathol; 2018 Aug; 245(4):410-420. PubMed ID: 29732561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
    Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
    Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.